More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Tirzepatide's Association With BP Reduction Reinforced With ABPM Data Combination GLP-1/GIP receptor agonist is currently approved for T2D and weight loss Feb 05, 2024
Durable Weight Loss Follows Just a Few Injections of Novel Drug Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
U.S. Officials Call for More Programs, Education to Improve Diets in America More research on "gut-brain axis" is also needed Feb 02, 2024
Alleged Lewd Doc Acquitted; AI Detects Guns at Hospital; Obesity Bill of Rights Health news and commentary from around the Web gathered by 51˶ staff Feb 01, 2024
Perioperative Complications Not Deciding Factor Between Two Bariatric Procedures Short-term complications and safety similar for sleeve gastrectomy and RYGB Jan 30, 2024
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
How Should Health Plans Respond to Surging Interest in Weight Loss Drugs? Studies suggest coverage is warranted for certain populations Jan 16, 2024
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
More Kids Getting Their Hands on Nonprescription Weight-Loss Products Almost 10% of kids said they've tried at least one drug or dietary supplement in their lifetime Jan 10, 2024
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
No Increased Risk of Suicidal Ideation With GLP-1 Drugs Semaglutide shows lower risk of suicidal ideation than other obesity, diabetes drugs Jan 08, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024
Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes News and commentary from the endocrinology world Jan 02, 2024
Dulaglutide, Weight Gain, and Smoking Cessation; New Year's Eye Injuries Also in TTHealthWatch: Doxycycline for STI prevention and the risks of AI in medicine Dec 30, 2023 podcast
Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth News and commentary from the endocrinology world Dec 26, 2023
Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry News and commentary from the endocrinology world Dec 19, 2023
Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gain Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadavers Health news and commentary from around the Web gathered by 51˶ staff Dec 14, 2023
Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelves News and commentary from the endocrinology world Dec 12, 2023
USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesity Behavioral interventions should be main approach; insufficient data to back pharmacologic therapy Dec 12, 2023
Teens' High BMI Tied to Early Chronic Kidney Disease "Enormous" risk increase seen in the highest BMI categories Dec 11, 2023
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Association strongest in patients with overweight, obesity Dec 07, 2023
Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxes Health news and commentary from around the Web gathered by 51˶ staff Dec 06, 2023
Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D News and commentary from the endocrinology world Dec 04, 2023
Year in Review: Obesity 2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI Dec 01, 2023
Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis News and commentary from the endocrinology world Nov 27, 2023
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd News and commentary from the endocrinology world Nov 21, 2023
Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
Want Lower Obesity Drug Costs? Medicare Holds the Key Medicare coverage will catalyze market competition Nov 17, 2023
Mall Doc Kiosks; Gaza Hospital Stormed; Rationing Semaglutide by Lifestyle Health news and commentary from around the Web gathered by 51˶ staff Nov 16, 2023
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes News and commentary from the endocrinology world Nov 14, 2023
Double Defibrillator More Effective for Obese Afib Patients Clinical trial affirms a better initial strategy Nov 12, 2023
Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim Meeting Delegates agree the current system is broken but disagree on the solution Nov 12, 2023